The vast majority of existing vaccines need to be kept cold, a costly and logistical challenge that limits access to millions of people living in poor and wartorn regions. But a new vaccine could surpass these storage limitations.
An experimental combination vaccine for tetanus and diphtheria remains effective when kept out of the fridge for a year or more, researchers report August 5 in Lancet Discovery Science . The team is now investigating whether the technique used for this vaccine can be applied to other vaccines, including those for hepatitis B and HPV.
We summarize the week’s scientific breakthroughs every Thursday.
The new Td vaccine…
Read the full article at SCIENCENEWS.ORG
